TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways.
Singh K, Han C, Fleming JL, Becker AP, McElroy J, Cui T, Johnson B, Kumar A, Sebastian E, Showalter CA, Schrock MS, Summers MK, Becker V, Tong ZY, Meng X, Manring HR, Venere M, Bell EH, Robe PA, Grosu AL, Haque SJ, Chakravarti A.
Singh K, et al. Among authors: cui t.
Sci Rep. 2023 Aug 1;13(1):12424. doi: 10.1038/s41598-023-32983-w.
Sci Rep. 2023.
PMID: 37528172
Free PMC article.